Chr Hansen Holding A S is more than just a company—it’s a symbol of Danish excellence in biotechnology, innovation, and sustainable business. Founded in 1874 by the visionary pharmacist Christian D.A. Hansen, the company began by producing rennet for cheesemaking. Today, nearly 150 years later, Chr. Hansen has grown into a global bioscience leader specializing in natural microbial solutions for the food, health, and agriculture sectors.
Headquartered in Hørsholm, Denmark, Chr. Hansen operates in over 30 countries and employs more than 3,800 people. Also, its scientific reach is remarkable: the company boasts a microbial strain bank with over 40,000 different strains—one of the largest collections in the global biotech industry. Each day, more than 1 billion servings of food consumed around the world contain ingredients developed by Chr. Hansen.
Additionally, this blend of heritage, innovation, and impact makes Chr. Hansen a cornerstone of not only the Danish economy but also the global movement towards sustainable and science-driven solutions.
Here are the key points on Chr Hansen Holding:
- Chr Hansen’s Foundation and Global Role: Founded in 1874 in Denmark, Chr Hansen has grown into a biotech leader. This is with over 3,800 employees in 30+ countries, specializing in microbials for food, health, and agriculture.
- Key Contribution to Denmark’s Biotech Ecosystem: Chr Hansen is central to Denmark’s life sciences success, reinvesting 7% of revenue into R&D and collaborating with local institutions to enhance innovation and exports.
- Commitment to Sustainability: Recognized as the world’s most sustainable company in 2019, Chr Hansen uses microbes to promote food preservation, reduce chemicals, and support natural health and sustainable farming.
- Strategic Growth and Innovation in Biotechnology: The company leverages its microbial library to develop solutions for food, health, and agriculture. Therefore, culminating in a merger with Novozymes in 2023 to form the largest biosolutions firm.
Chr Hansen Holding as an Anchoring Force in Denmark’s Biotech Ecosystem
Denmark is renowned for its robust life sciences sector, and Chr. Hansen plays a central role in this national success story. Also, Danish biotech and pharmaceutical exports represent a significant portion of national GDP, and Chr. Hansen contributes heavily to this through both direct exports and knowledge leadership.
Beyond economic gains, the company is a true innovator: it reinvests approximately 7% of its annual revenue into research and development—well above industry norms. This continuous investment fuels product innovation in areas like food preservation, digestive health, and agricultural efficiency.
Furthermore, Chr. Hansen engages in multiple partnerships with Danish universities, research institutes, and companies. These collaborations not only elevate Denmark’s profile in international science but also help upskill local talents and reinforce the nation’s reputation as a life sciences powerhouse.
Sustainability at the Heart of the Business
One of the most defining aspects of Chr. Hansen’s identity is its deep commitment to sustainability. Moreover, the company leverages the power of naturally occurring microbes to create products that enhance food preservation, reduce agricultural chemicals, and promote healthier lifestyles—all while diminishing environmental impact.
In recognition of its green mission, Chr. Hansen was named the world’s most sustainable company in 2019 by Corporate Knights, and it remained in the top rankings again in 2020. Besides, this achievement was not symbolic—it was driven by measurable results: for example, Chr. Hansen’s food cultures extend the shelf life of dairy products, reducing food waste at both the retail and consumer levels.
Moreover, the company’s probiotics promote gut health, enabling consumers to turn toward natural health solutions and away from synthetic or over-the-counter interventions. In agriculture, its bio-solutions reduce dependency on synthetic pesticides, a critical aspect of the shift toward global sustainable farming.
Strategic Growth Through Biotechnology
Chr. Hansen’s success comes from its meticulous approach to biotechnology. With decades of experience in fermentation and microbial science, the company has created a wide array of specialized products adaptable to diverse industries. In addition, these range from enzymes used in cheesemaking to probiotics added to dietary supplements and livestock feed.
Thanks to the strength and diversity of its microbial library, Chr. Hansen can quickly respond to market trends, whether that means enabling plant-based yogurt options, creating shelf-stable probiotic strains for tropical climates, or designing biological crop protection agents that match region-specific challenges.
What’s more, the company’s strategic outlook also led to a transformative moment in 2023, when Chr. Hansen merged with fellow Danish biotech firm Novozymes. This merger created the world’s largest pure-play biosolutions company.
Chr Hansen Holding Is a Trusted Name in a Changing World
In a time when consumers demand cleaner labels, fewer additives, ethical food sourcing, and sustainable agricultural practices, Chr. Hansen consistently delivers. Also, the company not only reflects consumer expectations but actively shapes industry standards through innovation backed by decades of microbiological expertise.
Chr. Hansen’s reputation for excellence has helped it maintain long-standing relationships with leading food manufacturers, pharmaceutical companies, and agricultural suppliers. Additionally, it has become a trusted name, not just in Denmark, but globally, for organizations seeking reliable, natural solutions that blend economic benefit with environmental responsibility.
For Denmark, Chr. Hansen Holding represents the best of national ambition: scientific integrity, global vision, and a proactive role in solving some of the 21st century’s most pressing global challenges. As the world progresses toward more sustainable and scientifically advanced futures, Chr. Hansen will undoubtedly continue to lead from the front—powered by microbes and driven by purpose.
Products and Services of Chr. Hansen Holding
Microbial Solutions for a Healthier Planet
Chr. Hansen Holding offers a wide portfolio of microbial-based products and natural ingredients designed to enhance food quality, optimize agricultural practices, and improve human and animal health. Moreover, the company’s core strength lies in its extensive microbial strain bank—comprising more than 40,000 bacterial strains—which enables it to customize and develop high-performance solutions across industries.
Food Cultures and Enzymes
The cornerstone of Chr. Hansen’s product portfolio is its food cultures and enzymes, which are primarily used in the fermentation of dairy products like cheese, yogurt, and buttermilk. Besides, these cultures deliver taste, texture, safety, and shelf life enhancements, playing an essential role in the daily diets of millions.
The company’s offerings in this segment include lactic acid bacteria and enzymes such as microbial rennet that support cheesemaking. Furthermore, these ingredients are part of over 1 billion servings of fermented food consumed daily worldwide, demonstrating Chr. Hansen’s far-reaching global impact.
Innovations also extend to plant-based and lactose-free dairy alternatives. Chr. Hansen supports this growing segment with specialized cultures that improve mouthfeel and deliver the tangy, authentic taste consumers expect from traditional dairy.
Probiotics for Human Health
In the health and nutrition market, Chr. Hansen has developed clinically tested probiotics aimed at improving gut health, immune response, and general well-being. These probiotics—often used in dietary supplements and infant formula—are based on strains like Lactobacillus and Bifidobacterium, widely known for their beneficial effects on the human microbiome.
Clinical documentation is central to Chr. Hansen’s approach. It ensures traceability, quality, and efficacy, making its probiotics a preferred choice among nutraceutical and pharma companies around the globe. For example, the company’s probiotic strain BB-12® is among the most documented Bifidobacterium in the world, supported by numerous studies on gastrointestinal and immune health.
Animal Health and Nutrition
Chr. Hansen also plays a crucial role in the global livestock industry through its animal health portfolio. The company develops probiotic solutions for ruminants, poultry, swine, and aquaculture that improve feed conversion ratios, stabilize gut flora, and reduce antibiotic usage in animal farming.
These products are based on well-researched microbial strains that balance digestive function and enhance nutrient absorption. As environmental concerns grow within the livestock industry, Chr. Hansen’s probiotics help reduce methane emissions, particularly in ruminants like cows, contributing to more sustainable farming practices.
Chr Hansen Holding Plant Health and Biological Crop Protection
In agriculture, Chr. Hansen produces a growing range of biological products that support sustainable crop cultivation. Its biostimulants and biopesticides use naturally occurring microbes to enhance plant health, optimize nutrient uptake, and protect against soil-borne diseases.
These microbiological agents are applied directly to seeds or soil and promote healthy root development and higher crop yields without relying on chemical fertilizers or pesticides. This is especially relevant in organic farming, where growers require solutions that meet natural production criteria.
Fermentation-Enabled Natural Colors
Another innovative product category includes fermentation-enabled natural coloring agents used in food and beverages. Chr. Hansen has developed a line of stable, vibrant colors made through microbial processes and natural sources—particularly beneficial for manufacturers replacing synthetic dyes in response to clean-label trends.
Customized Solutions and Technical Support
Chr. Hansen doesn’t only offer off-the-shelf products. A significant portion of its business comes from co-developing tailor-made solutions with customers. Working closely with global food manufacturers, pharmaceutical companies, and agribusinesses, the company provides end-to-end support—from strain selection and application testing to regulatory approval and post-launch optimization.
In this customer-centric model, Chr. Hansen’s experts often act as innovation partners, integrating microbial science into the core of the client’s product development framework. Whether it’s a dairy brand seeking longer shelf life with fewer preservatives, or a nutrition company targeting a specific health concern, solutions are created with pinpoint accuracy.
Digital Integration and Scientific Validation
Chr. Hansen is at the forefront of digitalization in bioscience. It uses data-driven technologies to accelerate fermentation processes, optimize microbial performance, and track strain behavior in different environments. Real-time process monitoring and AI-powered data analysis help ensure top-tier quality and production efficiency.
Rigorous scientific validation is another company hallmark. Products are regularly subjected to internal and external studies for safety, efficacy, and stability. In many cases, Chr. Hansen’s products are linked to published clinical studies, making them especially trusted in regulated sectors such as infant nutrition and pharmaceuticals.
Impact by Nature, Science by Design
Chr. Hansen’s slogan, “Impact by Nature,” encapsulates its ambition to deliver positive change through scientifically designed natural solutions. By leveraging the transformative potential of microbes, the company delivers safe, effective, and environmentally friendly products with applications that meet the needs of the modern world.
Conclusion: Chr Hansen Holding
Chr Hansen Holding A/S has proven itself to be far more than a traditional biotech company—it is a mission-driven innovator with global impact. Rooted in Danish scientific tradition and over 140 years of history, the company continues to develop solutions that address both human and environmental needs. Moreover, with a broad product line based on microbial science, Chr. Hansen serves industries as diverse as food, agriculture, nutrition, and pharmaceuticals.
By continually investing in research and committing to sustainability-driven goals, Chr Hansen Holding has not only affirmed its leadership in fermentation and probiotics. It has also cemented its reputation as a vital contributor to Denmark’s reputation in green innovation and bioeconomy. Besides, the recent merger with Novozymes further amplifies its global reach and unites two of Denmark’s most influential bioscience companies in the pursuit of a healthier, more sustainable world.
Frequently Asked Questions about Chr Hansen Holding
1. What does Chr Hansen Holding do?
Chr Hansen Holding develops natural microbial solutions used in food production, dietary supplements, agriculture, and animal health. Additionally, these include probiotics, enzymes, food cultures, natural colors, and biological crop protection products.
2. Why is Chr Hansen important to Denmark?
Chr Hansen represents a model of Danish scientific excellence, sustainability, and global innovation. Also, it plays a key role in Denmark’s life sciences industry and contributes significantly to the national economy and green exports.
